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Opening Remarks
I am fortunate to have been in the pigment cell field since my late teens. Over
the years, the subject of melanin pigmentation has become more interesting because
advances made in biology at the subcellular and molecular levels can be applied
to pigment cells, some practical problems have been solved, and the really difficult
subjects-those related to melanomas-seem to have some chance of solution. In
reciprocal fashion, investigations with pigment cells have helped advance our un-
derstanding of biological processes.
Some neoplasms are derived from tissues that are required for life, such as the
white blood cells, liver, brain, lungs, and skin. If an attempt to destroy the tissue
from which the neoplasm arose eliminated the normal cells as well as the malig-
nant, one would not be left with a viable subject. Other neoplasms, however, arise
from cells for which excellent replacement therapy is available: for example,
tumors of the thyroid, pituitary and adrenal glands. If an individual has a malig-
nancy of the thyroid gland, removal or destruction of all thyroid tissue could be
attempted because replacement therapy for loss of thyroid function would be easy.
Finally, some malignancies arise from cells that are not required for life and for
which no replacement therapy is essential. Included in this category would be neo-
plasms of the breast, ovaries, testes, pigment cells, and others. Of course, as yet,
we cannot carry out this kind of selective obliteration of a cell type with any great
degree of success. But melanocytes behave in ways suggesting that total destruction
of all normal and malignant pigment cells in a single patient could be feasible.
For example, some people spontaneously develop total vitiligo resulting in destruc-
tion of all their melanocytes. The cells disappear. People with vitiligo develop white
patches on the hands, face, and other parts of the body. One percent of the popula-
tion has vitiligo. However, total vitiligo is relatively rare. Theoretically, a person
with vitiligo should not develop a melanoma. But in a few known instances subjects
with vitiligo have developed melanomas, and some horses with the equivalent of
vitiligo frequently have melanomas. We know that the onset of vitiligo after devel-
opment of a melanoma is significant-occurring in 10-20 percent of patients. A
simple goal would be to induce total destruction of normal and malignant pigment
cells in a controlled manner. We cannot do that at present even though patients
with vitiligo lose nonmalignant melanocytes with ease. To achieve our goal we must
first understand a tremendous amount of basic biology. The hope that such infor-
mation will come forth provides the stimulus for having this nonclinical and non-
applied conference on pigment cell biology.
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